NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jan 29, 2024 $0.133 -0.23% $0.128 V 96.09% 1
Jan 29, 2024 $0.120 -9.96% $0.128 V 93.77% 1
Jan 29, 2024 $0.142 +6.22% $0.128 X 89.38% 0
Jan 29, 2024 Bullish $0.128 X 0
JS JS Pro
Jan 26, 2024 $0.122 -0.08% $0.133 X 91.52% 0
AlexVel AlexVel Pro
Jan 26, 2024 $0.132 +8.37% $0.133 V 99.26% 4
Jan 26, 2024 $0.136 +11.15% $0.133 V 98.19% 1
Jan 26, 2024 $0.131 +6.97% $0.133 V 97.98% 1
JS JS Pro
Jan 25, 2024 $0.120 +0.00% $0.122 X 98.28% 0
Jan 25, 2024 $0.134 +11.95% $0.122 V 89.97% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE